Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
about
Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, MozambiqueUptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive studyDeterminants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.Guidance on vaccination of HIV-infected children in Europe.Trends in hospitalizations among children and young adults with perinatally acquired HIV.Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesSurvival of HIV-infected children: a cohort study from the Asia-Pacific region.Time trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infectionHospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.Short-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country.Management of paediatric HIV-1 resistance.Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.Mortality among pulmonary tuberculosis and HIV-1 co-infected Nigerian children being treated for pulmonary tuberculosis and on antiretroviral therapy: a retrospective cohort study.Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.The impact of highly active antiretroviral therapy on the survival of vertically HIV-infected children and adolescents in Belo Horizonte, Brazil.Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.Clinical Outcomes and Hospitalizations among Children Perinatally Infected with HIV-1 in Baja California, Mexico.Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.Socioeconomic Status and Vulnerability to HIV Infection in Uganda: Evidence from Multilevel Modelling of AIDS Indicator Survey Data.Viral Sepsis in Children
P2860
Q28546341-6EFF3363-554E-4B9D-8101-1C70F62EC920Q30397919-D62F0420-9815-4B8F-89EC-E3D74CE7ADA2Q33553629-A439A502-242A-4D2F-9B79-054E1A46F0F1Q33559823-AF1A2BA4-EAA1-45D4-A58D-F369633C17A5Q33776928-E23B7F82-9865-4578-BC19-D7B375A0BC87Q34251138-1AED63C6-D502-4F00-BE24-D5EE9C8FCC50Q34432664-52CBD104-9CC2-4CA8-8795-1100D1551BE1Q34513045-F5A8E7AA-FECF-44C0-8EF5-34891B27457EQ34773604-3AB6CB11-B57A-4783-9511-4FDB10B75BC9Q35233180-ACFF93D3-71A5-439F-BC8D-179B3B26B96CQ35655827-CDEEAE99-214A-4DA9-BBB7-38C8EB01ED1EQ35901126-72D68E9F-1C86-49BA-8C08-227B5DC0EE86Q36154492-B1F5D304-18F2-4908-BBBB-0E6F09C6E38FQ37326138-6F07D0F3-1771-4EFC-8CA6-9B6AAA5A7BD1Q37494145-A394BB6B-A84D-498A-99A3-0EA387E13BD9Q37534454-394621E6-6072-4431-83BB-E54D5420BAE7Q42116942-B80434EB-0E1A-4464-ADC4-53AD4B9C3D6FQ42576594-3449597E-6735-492E-A693-A4711B9F3237Q45016203-00425092-06B7-4E75-951D-56DEDA39FADDQ45722098-22D5C859-A1D7-419D-9338-061F5F63D357Q46498877-CCF9304F-64DD-429D-909C-633D8DE26176Q46948089-2E56EE77-EFBC-403C-9049-DCF50C6A1106Q50545880-BC532A68-0571-4794-86E6-F48E7C1295C3Q55492747-C1ABFF0A-31F1-41EB-850D-EEEEE0731579Q57019179-79CA40F2-C74B-413C-9294-9AE452C1752D
P2860
Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Impact of highly active antire ...... iency virus-infected children.
@en
Impact of highly active antire ...... iency virus-infected children.
@nl
type
label
Impact of highly active antire ...... iency virus-infected children.
@en
Impact of highly active antire ...... iency virus-infected children.
@nl
prefLabel
Impact of highly active antire ...... iency virus-infected children.
@en
Impact of highly active antire ...... iency virus-infected children.
@nl
P2093
P1476
Impact of highly active antire ...... iency virus-infected children.
@en
P2093
Angel Nogales Espert
Jesús Ruiz Contreras
José Manuel Sánchez
José Tomás Ramos Amador
Julián Clemente Vivas
María Isabel González Tomée
Pablo Rojo Conejo
Paloma Ferrnado Vivas
Sira Fernández de Miguel
P304
P356
10.1097/01.INF.0000091282.70253.5F
P577
2003-10-01T00:00:00Z